Long Noncoding RNA ABHD11-AS1 Interacts with SART3 and Regulates CD44 RNA Alternative Splicing to Promote Lung Carcinogenesis
Public Domain
-
2024/03/01
Details
-
Personal Author:
-
Description:Hexavalent chromium [Cr(VI)] is a common environmental pollutant and chronic exposure to Cr(VI) causes lung cancer in humans, however, the mechanism of Cr(VI) carcinogenesis has not been well understood. Lung cancer is the leading cause of cancer-related death, although the mechanisms of how lung cancer develops and progresses have been poorly understood. While long non-coding RNAs (lncRNAs) are found abnormally expressed in cancer, how dysregulated lncRNAs contribute to carcinogenesis remains largely unknown. The goal of this study is to investigate the mechanism of Cr(VI)-induced lung carcinogenesis focusing on the role of the lncRNA ABHD11 antisense RNA 1 (tail to tail) (ABHD11-AS1). It was found that the lncRNA ABHD11-AS1 expression levels are up-regulated in chronic Cr(VI) exposure-transformed human bronchial epithelial cells, chronically Cr(VI)-exposed mouse lung tissues, and human lung cancer cells as well. Bioinformatics analysis revealed that ABHD11-AS1 levels are up-regulated in lung adenocarcinomas (LUADs) tissues and associated with worse overall survival of LUAD patients but not in lung squamous cell carcinomas. It was further determined that up-regulation of ABHD11-AS1 expression plays an important role in chronic Cr(VI) exposure-induced cell malignant transformation and tumorigenesis, and the stemness of human lung cancer cells. Mechanistically, it was found that ABHD11-AS1 directly binds SART3 (spliceosome associated factor 3, U4/U6 recycling protein). The interaction of ABHD11-AS1 with SART3 promotes USP15 (ubiquitin specific peptidase 15) nuclear localization. Nuclear localized USP15 interacts with pre-mRNA processing factor 19 (PRPF19) to increase CD44 RNA alternative splicing activating β-catenin and enhancing cancer stemness. Together, these findings indicate that lncRNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote cell malignant transformation and lung carcinogenesis. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0160-4120
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:185
-
NIOSHTIC Number:nn:20069256
-
Citation:Environ Int 2024 Mar; 185:108494
-
Contact Point Address:Zhishan Wang, Stony Brook Cancer Center, Department of Pathology, Stony Brook University, Stony Brook, NY, USA
-
Email:zhishan.wang@stonybrook.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2024
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:Environmental International
-
Collection(s):
-
Main Document Checksum:urn:sha-512:bd9de775cc940e3593a693aa0f8d48a0dd7823212a5902a4f741cc57ff9d1180d5bfb8053976877da6a89a78524914f2a7c68322766816887c27888fb89d734c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like